Laddar...
In vitro antibacterial activity of BMY-28142, a new extended-spectrum cephalosporin.
The in vitro activity of BMY-28142 was compared with that of cefotaxime, ceftazidime, moxalactam, and imipenem against 639 clinical isolates and a number of in vitro-selected resistant mutants. BMY-28142 was the most potent compound against the members of the family Enterobacteriaceae with a MIC for...
Sparad:
| Huvudupphovsmän: | , |
|---|---|
| Materialtyp: | Artikel |
| Språk: | en |
| Publicerad: |
1985
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC180098/ https://ncbi.nlm.nih.gov/pubmed/3859244 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|